Literature DB >> 9177392

Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.

C N Jones1, D Pei, P Staris, K S Polonsky, Y D Chen, G M Reaven.   

Abstract

Plasma glucose and insulin responses to a graded i.v. infusion of glucose were compared in two groups of glucose-tolerant women divided on the basis of their insulin sensitivity. Resistance to insulin-mediated glucose disposal was measured using the insulin suppression test, and the women studied were chosen to represent the highest and lowest quartiles of insulin resistance seen in the normal population. The sensitivity of the pancreatic beta-cell to glucose was assessed by measuring the glucose, insulin, and C peptide concentrations in response to continuous graded i.v. infusions of glucose at rates of 1, 2, 3, 4, 6, and 8 mg/kg x min for 40 min each. In addition, insulin secretion rates in response to the graded glucose infusion, calculated over each sampling period, were derived from deconvolution of peripheral plasma C peptide concentrations, using a two-compartment model of C peptide kinetics and standard parameters for C peptide clearance. Although plasma glucose concentrations were only slightly higher throughout the glucose infusion, the insulin concentrations were approximately doubled in the insulin-resistant subjects. When expressed as a function of the molar increments in plasma glucose achieved during the glucose infusion studies, the insulin-resistant women had a 90% higher (684 +/- 55 vs. 360 +/- 36 pmol/L x mmol/L; P < 0.001) total integrated plasma insulin response as the glucose concentration was increased from 5 to 9 mmol/L. However, the total integrated insulin secretory rate was only increased by 37% (1494 +/- 133 vs. 1093 +/- 125 pmol/mmol/L x min; P < 0.05) in the insulin-resistant group. This discrepancy suggested that insulin clearance was lower in the insulin-resistant subjects, and the calculation of this value, as the ratio of the total secretion of insulin to the area under the plasma insulin curve, was significantly lower in the insulin-resistant group (1.25 +/- 0.05 vs. 1.87 +/- 0.16 L/min x m2; P < 0.005). These results show that the hyperinsulinemia of insulin resistance results from an increase in insulin secretion secondary to a shift to the left of the glucose-stimulated insulin response curve as well as a decrease in insulin clearance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177392     DOI: 10.1210/jcem.82.6.3979

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

Review 1.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.

Authors:  M K Cavaghan; D A Ehrmann; K S Polonsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Logistic model of glucose-regulated C-peptide secretion: hysteresis pathway disruption in impaired fasting glycemia.

Authors:  Daniel M Keenan; Rita Basu; Yan Liu; Ananda Basu; Gerlies Bock; Johannes D Veldhuis
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

3.  Pantoprazole may improve beta cell function and diabetes mellitus.

Authors:  F Inci; M Atmaca; M Ozturk; S Yildiz; R Koceroglu; R Sekeroglu; S H Ipekci; L Kebapcilar
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 4.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

5.  Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.

Authors:  Abdelfattah El Ouaamari; Jian-Ying Zhou; Chong Wee Liew; Jun Shirakawa; Ercument Dirice; Nicholas Gedeon; Sevim Kahraman; Dario F De Jesus; Shweta Bhatt; Jong-Seo Kim; Therese Rw Clauss; David G Camp; Richard D Smith; Wei-Jun Qian; Rohit N Kulkarni
Journal:  J Proteome Res       Date:  2015-07-30       Impact factor: 4.466

6.  A minimal C-peptide sampling method to capture peak and total prehepatic insulin secretion in model-based experimental insulin sensitivity studies.

Authors:  Thomas Lotz; Uli Göltenbott; J Geoffrey Chase; Paul Docherty; Christopher E Hann
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

7.  Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.

Authors:  Sun H Kim; Alice Liu; Danit Ariel; Fahim Abbasi; Cindy Lamendola; Kaylene Grove; Vanessa Tomasso; Gerald Reaven
Journal:  Diabetologia       Date:  2013-12-11       Impact factor: 10.122

Review 8.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

Review 9.  Control of glycaemia: from molecules to men. Minkowski Lecture 2003.

Authors:  M Stumvoll
Journal:  Diabetologia       Date:  2004-04-28       Impact factor: 10.122

10.  TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

Authors:  Dennis T Villareal; Heather Robertson; Graeme I Bell; Bruce W Patterson; Hung Tran; Burton Wice; Kenneth S Polonsky
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.